December 11, 2007
Article
Side effect may predict response to treatment.
Getting a rash with a drug that’s targeting the epidermal growth factor receptor (EGFR) may be a sign that it’s killing the tumor.
This Wasn't the Plan: The Truth
Living With Intention After a Cancer Diagnosis
June Lung Cancer Highlights: Top 5 Updates Patients Should Know
Could Shedding a Few Pounds Prevent a Breast Cancer Recurrence?